We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Good Clinical Practice in Overseas Trials Mandated Under FDA Proposed Rule
Good Clinical Practice in Overseas Trials Mandated Under FDA Proposed Rule
March 1, 2013
Sponsors seeking a green light to market a medical device in the U.S. would have to demonstrate that any overseas clinical trials of the product conformed to good clinical practice, according to an FDA proposed rule.